Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05411835 · ClinicalTrials.gov registry record · Early Phase 1
Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT05411835 is a Early Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 5 participants.
The verdict
NCT05411835, a Early Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if an oral ketone beverage is safe and well-tolerated during moderate intensity exercise in participants with long-chain fatty acid oxidation disorders and if it will raise blood ketones to levels similar to that reported among normal healthy subjects.
Interventions
- DIETARY_SUPPLEMENT Nutritional Ketone Supplement
- DIETARY_SUPPLEMENT Isocaloric Placebo Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2024-01-22 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05411835
The ClinicalTrials.gov registry entry for NCT05411835 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nutritional Ketone Supplement is the first listed.
NCT05411835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05411835 about?
NCT05411835 is a clinical study titled "Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders". The purpose of the study is to determine if an oral ketone beverage is safe and well-tolerated during moderate intensity exercise in participants with long-chain fatty acid oxidation disorders and if it will raise blood ketones to levels similar to that reported among normal healthy subjects.
What is the current status of trial NCT05411835?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2022-08-01. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT05411835?
The interventions under investigation include: Nutritional Ketone Supplement (DIETARY_SUPPLEMENT), Isocaloric Placebo Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05411835?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.